NCT00576537View on ClinicalTrials.gov

Tumor Lysate Pulsed Dendritic Cell Immunotherapy for Patients With Brain Tumors

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 31, 2001

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2011

Conditions
Glioblastoma
Interventions
BIOLOGICAL

Dendritic Cell Immunotherapy

Patients will receive four vaccines.

Trial Locations (1)

90048

Cedars Sinai Medical center, Los Angeles

All Listed Sponsors
lead

Cedars-Sinai Medical Center

OTHER

NCT00576537 - Tumor Lysate Pulsed Dendritic Cell Immunotherapy for Patients With Brain Tumors | Biotech Hunter | Biotech Hunter